The trial, sponsored by the Alzheimer's Association, aims to evaluate a couples counseling intervention designed to improve the psychosocial well-being of both partners in a relationship affected by early-stage Alzheimer's disease. Given the increasing prevalence of Alzheimer's and the significant emotional burden it places on caregivers and patients alike, this intervention could address a critical gap in supportive care. The market for Alzheimer's-related therapies is substantial, with a growing demand for non-pharmacological interventions that enhance quality of life. Competitive implications suggest that successful outcomes could position the Alzheimer's Association as a leader in psychosocial interventions, potentially attracting partnerships or funding for broader implementation. Diligence considerations should focus on the scalability of the intervention and its integration into existing care frameworks.